Justin Iver Odegaard
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 28
-
- Lung Cancer Treatments and Mutations 18
- Co-authors
- Ajay Chawla (23 shared papers)Lata Mukundan (9 shared papers)Christine R. Morel (6 shared papers)Divya Vats (6 shared papers)Roberto R. Ricardo-González (5 shared papers)Vidya Subramanian (2 shared papers)Anthony W. Ferrante (2 shared papers)Richard M. Locksley (6 shared papers)
- Journals
- Annals of Oncology (8 papers)Clinical Cancer Research (7 papers)Cell Metabolism (5 papers)Nature Medicine (5 papers)Journal of Molecular Diagnostics (4 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Justin Iver Odegaard
94 papers receiving 13.8k citations
Justin Iver Odegaard's Hit Papers
Peers
Comparison fields: 5 of 137
- Immunology 4.0k
- Cancer Research 2.6k
- Physiology 2.3k
- Oncology 2.2k
- Epidemiology 2.8k
Countries citing papers authored by Justin Iver Odegaard
This map shows the geographic impact of Justin Iver Odegaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Iver Odegaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Iver Odegaard more than expected).
Fields of papers citing papers by Justin Iver Odegaard
This network shows the impact of papers produced by Justin Iver Odegaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Iver Odegaard. The network helps show where Justin Iver Odegaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Justin Iver Odegaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage-specific PPARγ controls alternative activation and improves insulin resistance Hit paper breakdown → | 2007 | 1830 |
| 2 | Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer Hit paper breakdown → | 2018 | 1307 |
| 3 | Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation Hit paper breakdown → | 2006 | 1194 |
| 4 | Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance Hit paper breakdown → | 2008 | 749 |
| 5 | Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat Hit paper breakdown → | 2014 | 737 |
| 6 | Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis Hit paper breakdown → | 2014 | 575 |
| 7 | Alternative Macrophage Activation and Metabolism Hit paper breakdown → | 2011 | 545 |
| 8 | Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis Hit paper breakdown → | 2013 | 544 |
| 9 | Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer Hit paper breakdown → | 2019 | 486 |
| 10 | Comprehensive analysis of normal adjacent to tumor transcriptomes Hit paper breakdown → | 2017 | 435 |
| 11 | 2018 | 367 | |
| 12 | 2009 | 324 | |
| 13 | 2018 | 316 | |
| 14 | Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies Hit paper breakdown → | 2020 | 286 |
| 15 | 2014 | 285 | |
| 16 | 2012 | 248 | |
| 17 | 2013 | 234 | |
| 18 | 2010 | 218 | |
| 19 | 2008 | 216 | |
| 20 | 2019 | 197 |
About Justin Iver Odegaard
Justin Iver Odegaard is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Parasitology, Immunology and Oncology, having authored 96 papers that have together received 14.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (28 papers), Lung Cancer Treatments and Mutations (18 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers), Parasites and Host Interactions (11 papers), Genetic factors in colorectal cancer (10 papers), Immune cells in cancer (9 papers), Immune Cell Function and Interaction (7 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Immunology (4.0k citations), Cancer Research (2.6k citations), Physiology (2.3k citations), Oncology (2.2k citations) and Epidemiology (2.8k citations). Justin Iver Odegaard has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Ajay Chawla, Lata Mukundan, Christine R. Morel, Divya Vats, Roberto R. Ricardo-González, Vidya Subramanian, Anthony W. Ferrante, Richard M. Locksley, Frank Brombacher and Yifu Qiu. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Cell Metabolism, Nature Medicine and Journal of Molecular Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.